US 12,435,081 B2
Methods of treatment using BCN057 and BCN512
Andrew J. Norris, Los Angeles, CA (US); and Sudip Chakrabortty, San Jose, CA (US)
Assigned to BCN Biosciences L.L.C.
Filed by BCN Biosciences L.L.C., Inglewood, CA (US)
Filed on Jun. 13, 2022, as Appl. No. 17/839,199.
Application 17/839,199 is a continuation of application No. 17/001,592, filed on Aug. 24, 2020, granted, now 11,358,964.
Claims priority of provisional application 62/891,338, filed on Aug. 24, 2019.
Prior Publication US 2023/0035771 A1, Feb. 2, 2023
Int. Cl. C07D 471/04 (2006.01); C07D 241/04 (2006.01)
CPC C07D 471/04 (2013.01) [C07D 241/04 (2013.01)] 8 Claims
 
1. A compound of Formula C,

OG Complex Work Unit Chemistry
wherein R1=Br, I, Cl, NH2, OH, (CH2)n—CH3 (n=1-26) or substituted or unsubstituted aryl;
R2=Br, I, H, NH2, OH, CH3, (CH2)n—CH3 (n=0-26) or substituted or unsubstituted aryl;
R3=Br, I, H, NH2, OH, CH3, (CH2)n—CH3 (n=0-26) or substituted or unsubstituted aryl; and
R4=Br, I, Cl, H, NH2, OH, (CH2)n—CH3 (n=1-26) or substituted or unsubstituted aryl.